CAB39 and hypertrophic cardiomyopathy: In transgenic mice with the α-MHC mutation R403Q, miR-195 upregulation and subsequent repression of Cab39 in the heart leads to hypertrophic cardiomyopathy owing to inhibition of Lkb1/Strad/Cab39-dependent AMPK signaling (Chen et al., 2012).